Virginia Retirement Systems Et Al Axsome Therapeutics, Inc. Transaction History

Virginia Retirement Systems Et Al

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $205,561 - $268,212	-3,100 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$68.34 - $85.84 $211,854 - $266,104	3,100 New	3,100 $221,000
Q1 2020 May 12, 2020	SELL	$41.2 - $101.31 $531,480 - $1.31 Million	-12,900 Closed	0 $0
Q4 2019 Jan 27, 2020	SELL	$16.71 - $106.24 $85,221 - $541,824	-5,100 Reduced 28.33%	12,900 $1.33 Million
Q3 2019 Oct 22, 2019	BUY	$20.24 - $29.16 $66,792 - $96,228	3,300 Added 22.45%	18,000 $364,000
Q2 2019 Jul 26, 2019	BUY	$13.46 - $25.75 $197,862 - $378,525	14,700 New	14,700 $379,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.43B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.